The goal of the BVMC Pilot/Demonstration Projects Program (PPP) is to fund promising projects that take advantage of new clinical research opportunities in rare diseases. Typically, these projects demonstrate feasibility and generate proof-of-concept data for future grant funding and clinical studies. These projects will have potential for high impact to the relevant projects in the BVMC. We will support a minimum of 3 or a maximum of 5 pilot projects (one per year) for the duration of the grant.
Aim : To select, fund, and oversee high-quality pilot project proposals relevant for BVMC projects. The Administrative Unit will manage pilot projects, but the BVMC Executive Steering Committee will formulate decisions regarding project funding, taking into consideration clinical research potential in rare diseases, thematic relationship to the aims and scope of the BVMC, quality of the proposal, feasibility in projected time frame, and ability to support promising junior investigators. The Genetics, Statistics and Analysis Core will provide experimental design, genetic and statistical analysis support as needed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54NS065705-06
Application #
8913455
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Moy, Claudia S
Project Start
Project End
Budget Start
2014-09-30
Budget End
2015-07-31
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Strickland, Corinne D; Eberhardt, Steven C; Bartlett, Mary R et al. (2017) Familial Cerebral Cavernous Malformations Are Associated with Adrenal Calcifications on CT Scans: An Imaging Biomarker for a Hereditary Cerebrovascular Condition. Radiology 284:443-450
Kasthuri, Raj S; Montifar, Megan; Nelson, Jeffrey et al. (2017) Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia. Am J Hematol :
Zou, Xiaowei; Hart, Blaine L; Mabray, Marc et al. (2017) Automated algorithm for counting microbleeds in patients with familial cerebral cavernous malformations. Neuroradiology 59:685-690
Pilli, Vinod K; Chugani, Harry T; Juhász, Csaba (2017) Enlargement of deep medullary veins during the early clinical course of Sturge-Weber syndrome. Neurology 88:103-105
Lo, Warren D; Kumar, Riten (2017) Arterial Ischemic Stroke in Children and Young Adults. Continuum (Minneap Minn) 23:158-180
Tang, Alan T; Choi, Jaesung P; Kotzin, Jonathan J et al. (2017) Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature 545:305-310
Offermann, Elizabeth A; Sreenivasan, Aditya; DeJong, M Robert et al. (2017) Reliability and Clinical Correlation of Transcranial Doppler Ultrasound in Sturge-Weber Syndrome. Pediatr Neurol 74:15-23.e5
Merkel, Peter A; Manion, Michele; Gopal-Srivastava, Rashmi et al. (2016) The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis 11:66
Choquet, Hélène; Trapani, Eliana; Goitre, Luca et al. (2016) Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1. Free Radic Biol Med 92:100-9
Kavanaugh, Brian; Sreenivasan, Aditya; Bachur, Catherine et al. (2016) [Formula: see text]Intellectual and adaptive functioning in Sturge-Weber Syndrome. Child Neuropsychol 22:635-48

Showing the most recent 10 out of 42 publications